透析相关淀粉样瘤进展为病理性骨折
本文报告一例80岁终末期肾病女性患者,维持性血液透析8年,左股骨颈透析相关淀粉样瘤在2年内逐渐增大并进展为病理性骨折,描述了其独特的临床、影像和病理表现,并提及可能降低相关病理性骨折风险的预防措施。
要点
- 长期血液透析患者出现局限性骨关节软组织淀粉样沉积时,需考虑淀粉样瘤可能。
- 透析相关淀粉样瘤可逐渐增大并导致病理性骨折。
- 原文提及某些预防措施可能降低相关病理性骨折风险。
核心结论
- 长期血液透析患者的左股骨颈透析相关淀粉样瘤在2年期间逐渐增大,并进展为病理性骨折。
- 原文提及某些预防措施可能降低发生相关病理性骨折的风险。
研究设计与样本
- 个案报告,报告一例80岁终末期肾病女性患者,接受血液透析8年,左股骨颈透析相关淀粉样瘤在2年期间逐渐增大。
临床应用与阅片要点
- 原文提及某些预防措施可能降低发生相关病理性骨折的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Amyloidosis is the extracellular deposition of amyloid protein fibrils, and this condition may be hereditary or acquired. Patients undergoing long-term hemodialysis are particularly at risk for developing acquired amyloidosis. A rare form of amyloidosis is an amyloidoma or amyloid tumor, which occurs when amyloid focally deposits in a section of the musculoskeletal system, most commonly in the osteoarticular system. Here, we present a case of a hemodialysis-related amyloidoma of the left femoral neck in an 80-year-old woman with end-stage renal disease on hemodialysis for 8 years. The purpose of this report is to provide an account of the unique clinical, imaging, and histopathologic manifestation of a dialysis-related amyloidoma that progressively enlarges over a 2-year period. This report also highlights some prophylactic measures that may reduce the risk of developing an associated pathologic fracture.
引用
- Baal JD, Horvai AE, Link TM, et al. Progression of dialysis-related amyloidoma towards pathologic fracture. Skeletal Radiol. 2018. PMID: 29946879. doi:10.1007/s00256-018-3009-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。